These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34547494)
21. Coronavirus disease 2019 (COVID-19) pandemic: how countries should build more resilient health systems for preparedness and response. Wang Z; Duan Y; Jin Y; Zheng ZJ Glob Health J; 2020 Dec; 4(4):139-145. PubMed ID: 33312747 [TBL] [Abstract][Full Text] [Related]
22. The mathematical relationship between COVID-19 cases and socio-economic indicators of OECD countries. Catalbas MC; Burken S Pathog Glob Health; 2022 Sep; 116(6):376-388. PubMed ID: 35037595 [TBL] [Abstract][Full Text] [Related]
23. Does the Public Health Security Capacity Provide Better Preparedness for Health Emergencies? A Cross-Sectional Analysis of 180 Countries During the COVID-19 Outbreak. Durmuş V Disaster Med Public Health Prep; 2022 Dec; 17():e322. PubMed ID: 36503607 [TBL] [Abstract][Full Text] [Related]
24. Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries. Wei C; Lee CC; Hsu TC; Hsu WT; Chan CC; Chen SC; Chen CJ Epidemiol Infect; 2020 Dec; 149():e1. PubMed ID: 33413705 [TBL] [Abstract][Full Text] [Related]
25. Impact of pre-COVID-19 epidemic preparedness on the trajectory of the pandemic in African countries. Maruta T; Moyo S Afr J Lab Med; 2022; 11(1):1571. PubMed ID: 35402199 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward. Impouma B; Mboussou F; Farham B; Makubalo L; Mwinga K; Onyango A; Sthreshley L; Akpaka K; Balde T; Atuhebwe P; Gueye AS; Zawaira F; Rees H; Cabore J; Moeti M Epidemiol Infect; 2022 Jul; 150():e143. PubMed ID: 35818789 [TBL] [Abstract][Full Text] [Related]
27. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
28. The level of countries' preparedness to health risks during Covid-19 and pre-pandemic: the differential response to health systems building blocks and socioeconomic indicators. Da'ar OB; Kalmey F Health Econ Rev; 2023 Mar; 13(1):16. PubMed ID: 36917372 [TBL] [Abstract][Full Text] [Related]
29. Relationship Between High Organ Donation Rates and COVID-19 Vaccination Coverage. Inoue Y Front Public Health; 2022; 10():855051. PubMed ID: 35480588 [TBL] [Abstract][Full Text] [Related]
30. Addressing COVID-19 vulnerabilities: How do we achieve global health security in an inequitable world. Šehović AB; Govender K Glob Public Health; 2021; 16(8-9):1198-1208. PubMed ID: 33870859 [TBL] [Abstract][Full Text] [Related]
31. Age and Ageing During the COVID-19 Pandemic; Challenges to Public Health and to the Health of the Public. Clarfield AM; Dwolatzky T Front Public Health; 2021; 9():655831. PubMed ID: 34778158 [TBL] [Abstract][Full Text] [Related]
32. How to pay primary care physicians for SARS-CoV-2 vaccinations: An analysis of 43 EU and OECD countries. Milstein R; Shatrov K; Schmutz LM; Blankart CR Health Policy; 2022 Jun; 126(6):485-492. PubMed ID: 35367056 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic. Sharun K; Dhama K Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393 [TBL] [Abstract][Full Text] [Related]
34. The spatial linkage mechanism: medical level, public health security, and economic climate from 19 OECD EU countries. Fu R; Zheng B; Liu T; Xie L Front Public Health; 2023; 11():1090436. PubMed ID: 37435514 [TBL] [Abstract][Full Text] [Related]
36. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
37. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
38. Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries. Bert F; Scaioli G; Vola L; Accortanzo D; Lo Moro G; Siliquini R Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742479 [TBL] [Abstract][Full Text] [Related]
39. The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout. Zaqout A; Daghfal J; Alaqad I; Hussein SAN; Aldushain A; Almaslamani MA; Abukhattab M; Omrani AS Int J Infect Dis; 2021 Jul; 108():116-118. PubMed ID: 33992763 [TBL] [Abstract][Full Text] [Related]
40. Validation analysis of Global Health Security Index (GHSI) scores 2019. Boyd MJ; Wilson N; Nelson C BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33106239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]